ProteoSpin™ Total Protein Concentration, Detergent Clean-Up and Endotoxin Removal Kits
For rapid and efficient endotoxin removal from proteins and peptides
For research use only and NOT intended for in vitro diagnostics.
ProteoSpin™ Total Protein Concentration, Detergent Clean-Up and Endotoxin Removal Kits
For rapid and efficient endotoxin removal from proteins and peptides
Register today to receive an exclusive 15% off* on your first order.
Features and Benefits
- Columns bind proteins of interest while endotoxins flow through
- Reduce endotoxin levels to less than 0.01 EU/µg of protein
- Proteins are desalted
- Greater than 95% protein recovery
- Concentrate protein samples and remove detergents at the same time
- Effectively remove a wide range of detergents including SDS, Triton® X-100, CHAPS, NP-40, and Tween 20
- Purification is based on spin column chromatography that uses Norgen’s resin separation matrix
The ProteoSpin™ Total Protein Concentration, Detergent Clean-Up and Endotoxin Removal Kits are designed for the rapid removal of endotoxins from previously purified proteins or peptides, with protein recoveries of > 95% being achieved. Endotoxins, also known as lipopolysaccharides, are cell-membrane components of Gram-negative bacteria such as E. coli. Endotoxins liberated by Gram-negative bacteria are frequent contaminations of protein solutions derived from bioprocesses. Due to the high toxicity of endotoxins in vivo and in vitro, their removal from protein preparations is often necessary prior to the use of the protein in downstream applications. These kits efficiently reduce endotoxin levels to ≤ 0.01 EU/mg of protein, using spin column chromatography based on Norgen’s proprietary resin as the separation matrix. These kits are highly efficient in removing many different salts commonly used in the laboratory including, but not limited to, MgCl2, NaCl, KCl, CaCl2, LiCl and CsCl. The purified protein samples can be used in a number of downstream applications including sequencing, cloning, and in vitro and in vivo introduction into cells and organisms for various purposes. The simultaneous removal of salts while concentrating a dilute protein solution makes the kit a convenient method for preparing proteins before running many downstream applications such as SDS-PAGE, isoelectric focusing, X-ray crystallography, NMR spectroscopy, mass spectroscopy and other applications.
Mini Kit
The ProteoSpin™ Total Protein Concentration, Detergent Clean-Up and Endotoxin Removal Mini Kit is designed for the rapid removal of endotoxins from up to 200 μg of previously purified proteins or peptides, with protein recoveries of > 95% being achieved.
Maxi Kit
The ProteoSpin™ Total Protein Concentration, Detergent Clean-Up and Endotoxin Removal Maxi Kit is designed for the rapid removal of endotoxins from up to 4 mg of previously purified proteins or peptides, with protein recoveries of > 95% being achieved.
Details
Supporting Data
Kit Specifications
|
|
Maximum Protein Input |
200 μg
|
Maximum Column Volume Input |
600 μL
|
Molecular Weight of Recovered Proteins | No Molecular Weight cut-off |
Final Endotoxin Levels |
≤ 0.01 EU/μg protein
|
Protein Recovery |
90-95%
|
% Detergent Removal | 90-95% |
Detergents that can be Removed | Including Triton® X-100, CHAPS, NP-40 and Tween 20 |
Minimum Elution Volume |
50 μL
|
Time to Complete 10 Purifications |
20 minutes
|
Storage Conditions
All solutions should be kept tightly sealed and stored at room temperature. This kit is stable for 2 years from the date of shipment.
Component | Cat. 22800 (25 preps) | Cat. 22200 (4 preps) |
---|---|---|
Binding Buffer J | 8 mL | 8 mL |
Binding Buffer N | 4 mL | 20 mL |
Wash Solution M | 50 mL | 130 mL |
Wash Solution CIP | 20 mL | 60 mL |
Wash Solution N | 30 mL | 130 mL |
Wash Solution NIP | 20 mL | 60 mL |
Elution Buffer G | 6 mL | 20 mL |
Endotoxin Removal Solution | 1.5 mL | 1.5 mL |
Protein Neutralizer EF | 2 mL | 2 mL |
Maxi Spin Columns (assembled with Collection Tubes) | - | 4 |
Mini Spin Columns | 25 | - |
Collection Tubes | 25 | - |
Maxi Spin Columns (assembled with Collection Tubes) | 4 | |
Elution Tubes (1.7 mL) | 25 | - |
Elution Tubes (50 mL) | 4 | - |
Product Insert | 1 | 1 |
Documentation
FAQs
Mini
The protein solution may not be flowing through the column due to one or more of the following:
- During the binding step for Protein Concentration and Detergent Clean-Up:
- Centrifugation speed was too low.
Check the centrifuge to ensure that it is capable of generating 5,200 x g (~8,000 RPM). Sufficient centrifugal force is required to move the liquid phase through the resin. Centrifugation speeds may be increased to 14,000 x g (~14,000 RPM), but this speed should not be exceeded.
- Inadequate spin time.
Spin an additional two minutes to ensure that the liquid is able to flow completely through the column.
- Cellular debris is present in the protein solution.
Prior to the sample preparation step, filter the sample with a 0.45 µM filter or spin down insoluble materials. Solid, insoluble materials can cause severe clogging problems.
- Protein solution is too viscous.
Dilute the protein solution and adjust the pH to either 3.5 - 4 or 7 with the appropriate Binding Buffer. Highly viscous materials due to high protein concentrations can slow down flow rate significantly.
- Protein solution is not completely dissolved.
Dissolve the sample in a larger amount of buffer. Solid, insoluble materials can cause clogging problems.
- Centrifugation speed was too low.
- For Endotoxin Removal:
- Centrifugation speed was too low.
Check the centrifuge to ensure that it is capable of generating 5,200 x g (~8,000 RPM). Sufficient centrifugal force is required to move the liquid phase through the resin. Centrifugation speeds may be increased to 14,000 x g (~14,000 RPM), but this speed should not be exceeded.
- Inadequate spin time.
Spin for an additional minute to ensure that the liquid is able to flow through the column.
- Cellular debris is present in the protein solution.
Prior to the sample preparation step, filter the sample with a 0.45 µM filter or spin down insoluble materials. Solid, insoluble materials can cause clogging problems.
- Centrifugation speed was too low.
Poor peptide/protein recovery could be due to one or more of the following:
- Incorrect pH adjustment of protein sample.
It is important that the proper amount of the appropriate Binding Buffer is added to the protein sample in order to adjust the pH to either 3.5 - 4 or 7 prior to loading onto the column.
- Incorrect procedure was used.
Ensure that the acidic protocol was used for total proteins and the basic protocol was used for basic proteins.
Poor peptide recovery for Endotoxin Removal could be due to one or more of the following:
- Input protein solution is very high in molarity.
The Binding Buffer J may not lower the pH of the protein solution sufficiently if the input protein solution has a very high molarity. Dilute the molarity of the input to < 50 mM with water. If the volume of the input amount is increased over the maximum 450 µL input, the sample can be split and processed using 2 columns.
- The appropriate amount of Binding Buffer J was not added.
Ensure that 20 µL of Binding Buffer J is added for every 500 µL of protein processed. The protein volume must not exceed 450 µL.
The eluted protein may be degraded due to one or more of the following:
A) For Protein Concentration and Detergent Clean-Up:
- Eluted protein solution was not neutralized.
Add 9.3 µL of Neutralizer to each 100 µL of eluted total proteins in order to adjust the pH to neutral. Some proteins are sensitive to high pH, such as the elution buffer at pH 12.5.
- Eluted protein was not neutralized quickly enough.
If eluted proteins are not used immediately, degradation will occur. We strongly suggest adding Neutralizer in order to lower the pH.
- Proteases may be present.
Use protease inhibitors during all steps of the Sample Preparation.
- Bacterial contamination of protein solution.
Prepare the protein sample with 0.015% sodium azide.
B) For Endotoxin Removal:
- Eluted protein was not neutralized.
Add 9.3 µL of Protein Neutralizer EF EF for every 100 µL of eluted protein in order to adjust the pH to neutral. Some proteins are sensitive to high pH, such as the Elution Buffer G.
- Bacterial contamination of protein solution.
The protein samples can be prepared with 0.015% sodium azide.
- Eluted protein was not neutralized quickly enough.
If the eluted protein is not neutralized immediately, degradation will occur. We strongly recommend adding Protein Neutralizer EF EF in order to lower the pH.
If the protein does not perform well in downstream applications for endotoxin removal, it may be because a different Elution Buffer was used. The provided Elution Buffer G has been optimized for endotoxin-free recoveries. The endotoxin-free properties of the eluted protein will be compromised if another Elution Buffer G is used. If a different Elution Buffer G other than the one provided is used, the buffer should also be checked for any components that may interfere with the application. Common components that are known to interfere are high salts, detergents, and other denaturants. Check the compatibility of your Elution Buffer with the intended use.
If endotoxin levels are high in the elution after the endotoxin removal protocol, it may be caused by:
- Using a different Elution Buffer.
The provided Elution Buffer G has been optimized for endotoxin-free recoveries. The endotoxin-free properties of the eluted protein will be compromised if another Elution Buffer is used. If a different Elution Buffer other than the one provided is used, the buffer should also be checked for endotoxin levels.
- Extremely high endotoxin levels in input protein.
Check the endotoxin levels of your protein input. The endotoxin levels of the eluted protein may be reduced significantly compared to the input.
Citations
Title | Inhibition of 4-1BBL-regulated TLR response in macrophages ameliorates endotoxin-induced sepsis in mice |
Citation | Europena Journal of Immunology 2014. |
Authors | BR Bang, SJ Kim, H Yagita, M Croft, YJ Kang |
Title | Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles |
Citation | Journal of Neurosciences 2014. |
Authors | DL Castillo-Carranza, U Sengupta, MJ Guerrero-Munoz, CA Lasagna-Reeves, JE Gearson, G Singh, DM Estes, ADT Barrett, KT Dineley, GR Jackson, R Kayed |
Title | Cross-protective effect of a novel multi-antigen-chimeric vaccine against Streptococcus and Staphylococcus aureus infection in mice |
Citation | Journal of Medical Microbiology 2014. |
Authors | L Yu, Z Fan, J Ma, C Tong, B Song, Z Zhu, Y Cui |
Title | Amino acids 89-96 of Salmonella typhimurium flagellin represent the major domain responsible for TLR5-independent adjuvanticity in the humoral immine response |
Citation | Cancer & Molecular Immunology 2014. |
Authors | L Zhang, Z Pan, X Kang, Y Yang, H Kang, N Zhang, JM Rosati, X Jiao |
Title | Variant screening of the serum amyloid A1 gene and functional study of the p.Gly90Asp variant for its role in athersclerosis |
Citation | Atherosclerosis 2013. |
Authors | Koon-Yeow Leow, Wilson Wen Bin Goh, Si-Zhen Tan, Jimmy Lim, Kenneth C. Ng, Vernon Min-Sen Oh, Adrian Fatt-Hoe Low, Chew-Kiat Heng |
Title | Improved protective efficacy of a chimeric staphylococcus aureus vaccine candidate IsdB(N126-P361)-Trap in mice |
Citation | Microbiology and Immunology 2013. |
Authors | L Yu, N Wang, J Ma, C Tong, B Song, J Chi, G Ma, Z Zhu, Y Cui |
Title | Identification and functional characterization of the goldfish (Carassius auratus L.) high mobility group box 1 (HMGB1) chromatin-binding protein |
Citation | Developmental and Comparative Immunology 2013. |
Authors | J Xie, JW Hodgkinson, C Li, N Kovacevic, M Belosevic |
Title | FCRL5 exerts binary and compartmet-specific influence on innate-like B-cell receptor signaling |
Citation | PNAS 2013. |
Authors | Zilu Zhu, Ran Li, Hao Li, Tong Zhou, Randall Davis |
Title | Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes |
Citation | Endocrinology 2012. |
Authors | Motoko Kanzaki et al. |
Title | Effect of serum amyloid A1 treatment on global gene expression in THP-1-derived macrophages |
Citation | Inflammation Research 2012. |
Authors | Koon-Yeow Leow, Wilson Wen Bin Goh, Chew-Kiat Heng |